SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently facing intense community debate as investors weigh the firm's aggressive dilution strategy against the impact of recent Bitcoin price volatility and external macro pressures. Market participants are actively scrutinizing the company's high-leverage business model, with ongoing discussions polarized between those anticipating a major liquidation risk and others viewing the stock's recent weakness as a prime opportunity for accumulation.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors debate the impact of a short-seller report on its primary holdings and the company's delayed 10-K filing. Despite volatility and bearish pressure, the community remains divided, with many long-term holders viewing the pullback as a buying opportunity ahead of anticipated debt reduction and earnings results.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community buzz as investors brace for the late-breaking presentation of 40-week VELA trial data at the upcoming American Academy of Dermatology annual meeting. The stock is seeing significant institutional accumulation and analyst upgrades, with shareholders actively debating the potential for a transformative buyout as the company solidifies its position as a best-in-class leader in the hidradenitis suppurativa treatment landscape.

"What's Updog?" is a Community Led token.

UpDog

UpDog is generating significant buzz as community members rally behind the meme-themed token, frequently sharing its contract address and encouraging others to join through active engagement on social platforms. While supporters highlight the community's longevity and thematic humor, detractors have surfaced concerns regarding the project's legitimacy and volatility.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for the treatment of rare kidney diseases, C3G and primary IC-MPGN. Investors are actively discussing the potential impact of this label expansion on long-term revenue growth and its role in bolstering the company's position as a buyout candidate, while monitoring how this news might trigger a short squeeze given the stock's high short interest.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is seeing intense retail activity as traders speculate on a potential short squeeze fueled by an exceptionally tight public float and high borrow rates. The community remains deeply divided, with bulls betting on explosive price volatility similar to past market runners, while bears warn of a pump-and-dump scheme driven by lack of institutional support and low trading volumes.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as the community debates whether the stock is a long-term AI infrastructure play or an overextended trade susceptible to profit-taking. Investors are actively discussing support levels and the impact of sector-wide pressure, while some highlight potential acquisition rumors or long-term growth as catalysts for future price action.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is seeing significant options activity and community debate as investors weigh the company's oncology pipeline progress against lingering patent cliff concerns and sluggish post-pandemic recovery. Traders are closely monitoring key support levels near 26-27 dollars, with many actively discussing the stock's potential for a breakout based on its high dividend yield and institutional accumulation.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for community discussion as traders debate its resilience amidst broader crypto market volatility and the rise of experimental tokens within its ecosystem. While some participants express concern over price fluctuations, others remain focused on developer momentum, institutional adoption, and the potential for long-term growth as a core infrastructure layer in decentralized finance.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is facing a sharp sell-off driven by investor concerns over cyclical memory pricing, potential AI demand shifts following industry reports on efficiency, and broad semiconductor distribution. While the community is deeply polarizeddebating whether this is a structural re-rating or a manipulative short trapmany traders are actively monitoring the stock's failure to rebound alongside broader market rallies while watching for key support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update

Lucid Diagnostics Inc. (NASDAQ:LUCD - Get Free Report) saw a large decline in short interest in the month of March. As of March 13th, there was short interest totaling 5,797,071 shares, a decline of 13.8% from the February 26th total of 6,727,046 shares. Based on an average daily trading volume...

Lucid Diagnostics (NASDAQ:LUCD) Earns Buy Rating from BTIG Research

BTIG Research reaffirmed a "buy" rating and set a $2.50 target price on shares of Lucid Diagnostics in a report on Monday...

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR...

Lucid Diagnostics (NASDAQ:LUCD) Rating Increased to Hold at Wall Street Zen

Wall Street Zen raised shares of Lucid Diagnostics from a "sell" rating to a "hold" rating in a research report on Saturday...

Lucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Estimates By $0.03 EPS

Lucid Diagnostics (NASDAQ:LUCD - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts...

Needham & Company LLC Reiterates Buy Rating for Lucid Diagnostics (NASDAQ:LUCD)

Needham & Company LLC reissued a "buy" rating and set a $3.00 price objective on shares of Lucid Diagnostics in a research note on Thursday...

Lucid Diagnostics Q4 Earnings Call Highlights

Lucid Diagnostics (NASDAQ:LUCD) reported higher fourth-quarter 2025 EsoGuard testing volume and revenue and highlighted progress on reimbursement initiatives, including a new U.S. Department of Veterans Affairs (VA) contract and ongoing discussions with Medicare and commercial payers.

Fourth-quarte...

Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates

Lucid Diagnostics (LUCD) delivered earnings and revenue surprises of -42.86% and +15.69%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025...

DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue Estimates

DarioHealth (DRIO) delivered earnings and revenue surprises of +48.88% and +2.17%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.

Lucid Diagnostics Inc

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

LUCD
Lucid Diagnostics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest LUCD News

LUCDLucid Diagnostics Inc